Trial intelligence / Profile preview

Tromsø Vitamin D and Type 2 Diabetes Prevention Study

NCT00685594Phase 3Completed

Sponsor
UiT The Arctic University of Norway
Start
Mar 2008
Primary completion
Mar 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vitamin D with Placebo (2 arms). Primary endpoint: Development of Diabetes Type 2 at 5 years. Started Mar 2008; status: completed.

02

Drugs

vitamin d
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00685594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00685594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call